Find Safinamide Methanesulfonate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Listed Dossiers

Listed Dossiers

FDF DossiersDRUG PRODUCT COMPOSITIONS

111RELATED EXCIPIENT COMPANIES

178EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 202825-46-5, Safinamide mesilate, (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate, Pnu-151774e, Nw-1015, Safinamide (mesylate)
Molecular Formula
C18H23FN2O5S
Molecular Weight
398.5  g/mol
InChI Key
YKOCHIUQOBQIAC-YDALLXLXSA-N
FDA UNII
YS90V3DTX0

Safinamide Methanesulfonate
1 2D Structure

Safinamide Methanesulfonate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic acid
2.1.2 InChI
InChI=1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1
2.1.3 InChI Key
YKOCHIUQOBQIAC-YDALLXLXSA-N
2.1.4 Canonical SMILES
CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O
2.1.5 Isomeric SMILES
C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
YS90V3DTX0
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (s)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide

2. 2-(4-(3-fluorobenzyloxy)benzylamino)propionamide

3. Fbap Methanesulfonate

4. Fce 26743

5. Fce 28073

6. Fce-26743

7. Fce-28073

8. Nw-1015

9. Pnu 151774e

10. Pnu-151774e

11. Safinamide

12. Safinamide Methanesulfonate

13. Xadago

2.3.2 Depositor-Supplied Synonyms

1. 202825-46-5

2. Safinamide Mesilate

3. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide Methanesulfonate

4. Pnu-151774e

5. Nw-1015

6. Safinamide (mesylate)

7. Safinamide Methanesulfonate

8. Pnu 151774e

9. Safinamide Mesylate [usan]

10. Fce-28073

11. Nw 1015

12. Safinamide Methansulfonate

13. Ys90v3dtx0

14. Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2s)-, Methanesulfonate (1:1)

15. 202825-46-5 (mesylate)

16. Safinamide Mesilate (jan)

17. Safinamide Mesylate (usan)

18. Safinamide Mesilate [jan]

19. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)-amino)propanamide Methanesulfonate

20. Chembl48582

21. (s)-2-[[4-[(3-fluorobenzyl)oxy]benzyl]amino]propanamide Methanesulfonate

22. Unii-ys90v3dtx0

23. Fce-28073(r-isomer)

24. Safinamidemesylate

25. Equfina (tn)

26. Xadago (tn)

27. Safinamide Mesylate Salt

28. Emd 1195686 Mesylate

29. Mls006010740

30. Schembl1665715

31. Dtxsid80942414

32. Hms3884o17

33. Safinamide Mesylate (fce28073)

34. Amy38833

35. Bcp16018

36. Ex-a2640

37. Hy-70057a

38. Mfcd15145475

39. S1472

40. Safinamide Mesilate [who-dd]

41. Akos015902297

42. Ccg-268636

43. Safinamide Methanesulfonate [mi]

44. Safinamide Mesylate [orange Book]

45. Ac-27739

46. As-75602

47. Pnu-151774e,fce28073

48. Smr004701699

49. Safinamide Mesylate Salt, >=98% (hplc)

50. Cs-0006742

51. Sw219452-1

52. D10191

53. J-013174

54. Q27294690

55. (s)-2[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate

56. (s)-(+)-2-(4-(3-fluorobenzyloxy) Benzylamino)propanamide, Methanesulfonate

57. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamidemethanesulfonate

58. (s)-2-[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate

59. (2s)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic Acid

60. Propanamide, 2-(((4-((3-fluorophenyl)methoxy)phenyl)methyl)amino)-, (s)-, Monomethanesulfonate

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 398.5 g/mol
Molecular Formula C18H23FN2O5S
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass398.13117117 g/mol
Monoisotopic Mass398.13117117 g/mol
Topological Polar Surface Area127 Ų
Heavy Atom Count27
Formal Charge0
Complexity438
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Xadago is indicated for the treatment of adult patients with idiopathic Parkinsons disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]
5.2 ATC Code

N04B


USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 34164

Submission : 2019-09-30

Status : Active

Type : II

Polpharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2020-11-05

Pay. Date : 2020-09-28

DMF Number : 35201

Submission : 2020-09-28

Status : Active

Type : II

Biophore

03

EPS
Not Confirmed

03

EPS
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-11-05

Pay. Date : 2020-09-26

DMF Number : 34399

Submission : 2020-02-13

Status : Active

Type : II

blank

04

EPS
Not Confirmed

04

EPS
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-10-14

Pay. Date : 2020-09-09

DMF Number : 35179

Submission : 2020-09-10

Status : Active

Type : II

blank

05

EPS
Not Confirmed

06

Merck Kgaa

Germany

USDMF

arrow
EPS
Not Confirmed

06

Merck Kgaa

Germany
arrow
EPS
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 28157

Submission : 2014-06-12

Status : Inactive

Type : II

blank

07

EPS
Not Confirmed

08

EPS
Not Confirmed

08

EPS
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-10-15

Pay. Date : 2020-08-12

DMF Number : 34628

Submission : 2020-02-27

Status : Active

Type : II

blank

09

EPS
Not Confirmed

09

EPS
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-10-15

Pay. Date : 2020-08-27

DMF Number : 35138

Submission : 2020-09-08

Status : Active

Type : II

blank

10

EPS
Not Confirmed
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

Merck KGaA

Germany
EPS
Not Confirmed
arrow

Merck KGaA

Germany
arrow
EPS
Not Confirmed

Safinamide Mesylate

Registration Number : 230MF10101

Registrant's Address : Frankfurter Strasse 250 64293 Darmstadt Germany

Initial Date of Registration : 2018-08-02

Latest Date of Registration : 2018-08-02

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Safinamide Mesylate IH

Date of Issue : 2025-02-27

Valid Till : 2028-02-26

Written Confirmation Number : WC-511n

Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...

Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Safinamide Mesylate

Date of Issue : 2025-02-27

Valid Till : 2028-02-26

Written Confirmation Number : WC-0511

Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...

Biophore

03

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-06-07

Valid Till : 2025-06-25

Written Confirmation Number : WC-0023

Address of the Firm : Survey no. 52,53,58,59,61 to 78,127&128, Pydibhimanvaram Village &Sy.No. 1,2,4t0...

blank

04

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-12-09

Valid Till : 2025-12-03

Written Confirmation Number : WC-0457

Address of the Firm : Sy No 544, 545 & 546, Bhiknoor (V), Bhiknoor (M), Kamareddy-503101, Telangana, I...

blank

05

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-11-02

Valid Till : 2025-07-02

Written Confirmation Number : WC-0182

Address of the Firm : Sy.No.239&240,Dothigudem Village,Pochampally MandalYadadri-Bhuvanagiri,Dist.-508...

blank

06

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-08-31

Valid Till : 2025-08-04

Written Confirmation Number : WC-0127

Address of the Firm : A1/B, SIPCOT Industrial Complex, Kudikadu, Cuddalore -607005

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Merck Group

Germany
EPS
Not Confirmed
arrow

Merck Group

Germany
arrow
EPS
Not Confirmed

Safinamide mesylate

Registrant Name : Korea Ezai Co., Ltd.

Registration Date : 2020-06-24

Registration Number : Su140-6-ND

Manufacturer Name : Merck KGaA

Manufacturer Address : Frankfurter Straße 250 D-64293 Darmstadt, Germany

blank

02

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide mesylate

Registrant Name : Saehan Pharmaceutical Co., Ltd.

Registration Date : 2022-05-27

Registration Number : Su532-8-ND

Manufacturer Name : Optimus Drugs Private Limite...

Manufacturer Address : Sy. No. 239 & 240, Dothigudem Village, Pochampally Mandal, Yadadri-Bhuvanagiri Distri...

blank

03

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide mesylate

Registrant Name : Aging Life Science Co., Ltd.

Registration Date : 2023-03-03

Registration Number : 434-52-ND

Manufacturer Name : Solara Active Pharma Science...

Manufacturer Address : A1/B, Sipcot Industrial Complex, Kudikadu Village Cuddalore-607 005, Tamil Nadu, Indi...

blank

04

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide mesylate

Registrant Name : Kukjeon Pharmaceutical Co., Ltd.

Registration Date : 2025-06-17

Registration Number : Number 173-58-ND

Manufacturer Name : Zhejiang Huahai Pharmaceutic...

Manufacturer Address : Chuannan Duqiao, Linhai, Zhejiang, 317016, China.

blank

05

EPS
Not Confirmed
arrow

arrow
EPS
Not Confirmed

Safinamide mesylate

Registrant Name : Lee Sung International Co., Ltd.

Registration Date : 2025-04-04

Registration Number : Thu 21-31-ND

Manufacturer Name : Honour Lab Limited Unit-IX

Manufacturer Address : Survey No. 332, 335, 336 & 341, Veliminedu Village, Chityal Mandal, Nalgonda District...

blank

06

EPS
Not Confirmed
arrow

arrow
EPS
Not Confirmed

Safinamide mesylate

Registrant Name : Hoosung Bio Co., Ltd.

Registration Date : 2025-05-09

Registration Number : Thu21-31-ND(1)

Manufacturer Name : Honour Lab Limited Unit-IX

Manufacturer Address : Survey No. 332, 335, 336 & 341, Veliminedu Village, Chityal Mandal, Nalgonda District...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

SAFINAMIDE MESYLATE

NDC Package Code : 73435-012

Start Marketing Date : 2020-12-23

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (20kg/20kg)

Marketing Category : BULK INGREDIENT

Biophore

02

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

SAFINAMIDE MESYLATE

NDC Package Code : 42973-301

Start Marketing Date : 2019-11-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

SAFINAMIDE MESYLATE

NDC Package Code : 59651-492

Start Marketing Date : 2024-01-10

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

04

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

SAFINAMIDE MESYLATE

NDC Package Code : 72640-005

Start Marketing Date : 2019-03-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

SAFINAMIDE MESYLATE

NDC Package Code : 59285-031

Start Marketing Date : 2020-07-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

HOSTER LABS PRIVATE LIMITED

Country
EPS
Not Confirmed
arrow

HOSTER LABS PRIVATE LIMITED

Country
arrow
EPS
Not Confirmed

SAFINAMIDE MESYLATE

NDC Package Code : 82708-0005

Start Marketing Date : 2021-03-17

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Polpharma

Poland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content

Safinamide Methanesulfonate

About the Company : Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API...

Polpharma API, part of a leading Polish pharmaceutical group, has over 70 years of experience in process development and cGMP manufacturing. We offer end-to-end solutions, from API development to scale-up, at our FDA-approved plant in Central Europe. Our expert team provides high-quality, tailor-made services for small molecule API clinical candidates, with strong regulatory support and world-class facilities. Trusted by global partners, we specialize in complex chemical processes and deliver exceptional customer experiences. Polpharma API – Your reliable European CDMO partner.
Polpharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Safinamide Mesylate

About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...

Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore

03

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Safinamide Mesylate

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Safinamide Mesylate

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.

Flag China
Digital Content Digital Content

Safinamide Mesylate

About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming ...

Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to global API standards, along with professional R&D and marketing teams, Hengkang’s operations span major pharmaceutical markets such as China, Europe, the CIS region, Japan, and South Korea. Hengkang has established long-term and stable relationships with nearly 70 countries overseas and hundreds of domestic enterprises.
Zhejiang Hengkang Pharmaceutical

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Safinamide Mesylate

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

07

Honour Lab

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Safinamide Methanesulfonate

About the Company : Honour is a leading global CDMO and specialty chemicals & ingredients manufacturer with seven facilities set to global standards of safety and quality. With our offerings, Honour S...

Honour is a leading global CDMO and specialty chemicals & ingredients manufacturer with seven facilities set to global standards of safety and quality. With our offerings, Honour Synthesis and Honour Specialty, we embrace the science of partnership and possibilities. Our 2500+ team delivers excellence to our pharmaceutical and biotechnology partners through practical solutions. Our commitment to transforming everyday life expands to specialty ingredients for electronics and pharma. Upholding top Environmental, Social, and Governance standards, we collaborate with stakeholders for sustainable, people-centric, transformative outcomes.
Company Banner

08

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide Mesylate

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

09

EPS
Not Confirmed
arrow
arrow
EPS
Not Confirmed

Safinamide Mesylate

About the Company : Nantong Jinghua Pharmaceutical is a public pharmaceutical company that was established in 1957, owns about 302 staff, located in No. 20, 3 Haibin Road, Yanhai Economic Development ...

Nantong Jinghua Pharmaceutical is a public pharmaceutical company that was established in 1957, owns about 302 staff, located in No. 20, 3 Haibin Road, Yanhai Economic Development Zone, Rudong, Nantong, Jiangsu, China. They are appointed as a high-new-technical enterprise by Jiangsu Scientific Technological Bureau. As a comprehensive, advanced, and innovative GMP company, they focus on the manufacture, R&D, and sales of APIs and pharmaceutical intermediates. The Company produces Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, Propylthiouracil, etc., in which the first five products have CEP certificates.
blank

10

Nifty Labs

India
EPS
Not Confirmed
arrow

Nifty Labs

India
arrow
EPS
Not Confirmed

Safinamide Methanesulfonate

About the Company : The company was founded by a technocrat Mr. D. Kesava Reddy in the year 2005. The Managing Director Mr. D. Kesava Reddy along with other three Board of Directors involved in contro...

The company was founded by a technocrat Mr. D. Kesava Reddy in the year 2005. The Managing Director Mr. D. Kesava Reddy along with other three Board of Directors involved in controlling the day to day operations of the company. The company has been focused on manufacturing and marketing of Bulk APIs (Bulk Drugs) and key Intermediates for APIs for Domestic and Global markets. About 60% is catered to domestic market and the rest 40% is catered to exports. The company does have a sister company named “Nifty Pharma Pvt. Ltd. located in Hyderabad focused on manufacturing & marketing of Semi-finished dosage forms.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675881000,"product":"SAFINAMIDE MESYLATE (OTHER) (LUT (ARN) N","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"OCPHSAE","customerCountry":"EGYPT","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"3930","totalValueFC":"19130.6","currency":"USD","unitRateINR":316000,"date":"09-Feb-2023","totalValueINR":"1580000","totalValueInUsd":"19130.6","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"7672691","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706639400,"product":"SAFINAMIDE MESYLATE (LUT(ARN)NOAD270323055216A DT 27\/03\/2023)(TAX INV MH1160000506 DT24.01.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"OCPHSAE","customerCountry":"EGYPT","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"3690","totalValueFC":"36425.9","currency":"USD","unitRateINR":302741.90499999997,"date":"31-Jan-2024","totalValueINR":"3027419.05","totalValueInUsd":"36425.9","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"7148361","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"407\/408,SHARDA CHAMBERS,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727116200,"product":"SAFINAMIDE MESYLATE","address":"HOSTER LABS PRIVATE LIMITED","city":"HYDERABAD","supplier":"HOSTER LABS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"JP BIO CORPRATIONS","customerCountry":"KOREA, REPUBLIC OF","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"1350","totalValueFC":"2640.1","currency":"USD","unitRateINR":110623.38499999999,"date":"24-Sep-2024","totalValueINR":"221246.77","totalValueInUsd":"2640.1","indian_port":"Hyderabad Air","hs_no":"29242990","bill_no":"4286779","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HOSTER LABS PRIVATE LIMITED, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742236200,"product":"SAFINAMIDE MESYLATE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MYUNGIN PHARMACOLTD","customerCountry":"KOREA, REPUBLIC OF","quantity":"42.50","actualQuantity":"42.5","unit":"KGS","unitRateFc":"1200","totalValueFC":"50576.8","currency":"USD","unitRateINR":103078.60470588236,"date":"18-Mar-2025","totalValueINR":"4380840.7","totalValueInUsd":"50576.8","indian_port":"Hyderabad Air","hs_no":"29242990","bill_no":"9114503","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696185000,"product":"SAFINAMIDE METHANESULFONATE (AS PER INVOICE)","address":"802, BLOCK-A, ALPINE HEIGHTS","city":"HYDERABAD, A.P.","supplier":"ZAKLADY FARMACEUTYCZNE POLPHARMA S A","supplierCountry":"POLAND","foreign_port":"WARSAW","customer":"AET LABORATORIES PRIVATE LTD","customerCountry":"INDIA","quantity":"22.00","actualQuantity":"22","unit":"KGS","unitRateFc":"1450","totalValueFC":"34902.5","currency":"EURO","unitRateINR":"132041.4","date":"02-Oct-2023","totalValueINR":"2904911.69","totalValueInUsd":"34902.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"8109268","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"WARSAW","supplierAddress":"19 PELPINSKA STR83-200 STAROGARD GDSDNF PL","customerAddress":"802, BLOCK-A, ALPINE HEIGHTS"}]
09-Feb-2023
18-Mar-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more
  • Deals

Details:

Pharmanovia will take over rights from CSL and will be responsible for all commercial and regulatory activities of Xadago (safinamide), for adult patients with idiopathic Parkinson's disease.


Lead Product(s): Safinamide Methanesulfonate

Therapeutic Area: Neurology Brand Name: Xadago

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pharmanovia

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement July 10, 2024

blank

01

CSL

Australia
arrow
EPS
Not Confirmed

CSL

Australia
arrow
EPS
Not Confirmed

Details : Pharmanovia will take over rights from CSL and will be responsible for all commercial and regulatory activities of Xadago (safinamide), for adult patients with idiopathic Parkinson's disease.

Product Name : Xadago

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

July 10, 2024

blank

Details:

Under the agreement, Newron and Zambon have ended their plans to run a clinical trial to test Xadago (safinamide) for uncontrolled movements induced by levodopa in people with Parkinson’s disease.


Lead Product(s): Safinamide Methanesulfonate

Therapeutic Area: Neurology Brand Name: Xadago

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: Zambon Group SpA

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement March 15, 2023

blank

02

EPS
Not Confirmed
EPS
Not Confirmed

Details : Under the agreement, Newron and Zambon have ended their plans to run a clinical trial to test Xadago (safinamide) for uncontrolled movements induced by levodopa in people with Parkinson’s disease.

Product Name : Xadago

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

March 15, 2023

blank

Details:

Under the agreement, Newron will sponsor the study and be responsible for Xadago (safinamide), development and execution, as well as leading on all related regulatory interactions. Newron and Zambon will evenly share the cost of the study.


Lead Product(s): Safinamide Methanesulfonate

Therapeutic Area: Neurology Brand Name: Xadago

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Newron Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement December 05, 2021

blank

03

Zambon Switzerland

Switzerland
arrow
EPS
Not Confirmed

Zambon Switzerland

Switzerland
arrow
EPS
Not Confirmed

Details : Under the agreement, Newron will sponsor the study and be responsible for Xadago (safinamide), development and execution, as well as leading on all related regulatory interactions. Newron and Zambon will evenly share the cost of the study.

Product Name : Xadago

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

December 05, 2021

blank

Details:

Eisai will take over by transfer the manufacturing and marketing approval of Equfina from Meiji. Eisai, as the manufacturer and distributor of Equfina in Japan, will continue to provide information on the proper usage of Equfina.


Lead Product(s): Safinamide Methanesulfonate

Therapeutic Area: Neurology Brand Name: Equfina

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Eisai

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement July 09, 2020

blank

04

EPS
Not Confirmed
EPS
Not Confirmed

Details : Eisai will take over by transfer the manufacturing and marketing approval of Equfina from Meiji. Eisai, as the manufacturer and distributor of Equfina in Japan, will continue to provide information on the proper usage of Equfina.

Product Name : Equfina

Product Type : Other Small Molecule

Upfront Cash : Undisclosed

July 09, 2020

blank

Details:

The marketing authorization application for safinamide in South Korea was submitted in July 2019, and through the approval of this application, South Korea became the first country in Asia outside of Japan to grant marketing approval for safinamide.


Lead Product(s): Safinamide Methanesulfonate

Therapeutic Area: Neurology Brand Name: Equfina

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 25, 2020

blank

05

Eisai

Japan
arrow
EPS
Not Confirmed

Eisai

Japan
arrow
EPS
Not Confirmed

Details : The marketing authorization application for safinamide in South Korea was submitted in July 2019, and through the approval of this application, South Korea became the first country in Asia outside of Japan to grant marketing approval for safinamide.

Product Name : Equfina

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 25, 2020

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - EQ 100MG BASE

USFDA APPLICATION NUMBER - 207145

read-more

DOSAGE - TABLET;ORAL - EQ 50MG BASE

USFDA APPLICATION NUMBER - 207145

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

API Stability Enhancers

read-more
read-more

Taste Masking

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Emulsifying Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 202825-46-5 / Safinamide Methanesulfonate API manufacturers, exporters & distributors?

Safinamide Methanesulfonate manufacturers, exporters & distributors 1

95

PharmaCompass offers a list of Safinamide Methanesulfonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Safinamide Methanesulfonate manufacturer or Safinamide Methanesulfonate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Safinamide Methanesulfonate manufacturer or Safinamide Methanesulfonate supplier.

PharmaCompass also assists you with knowing the Safinamide Methanesulfonate API Price utilized in the formulation of products. Safinamide Methanesulfonate API Price is not always fixed or binding as the Safinamide Methanesulfonate Price is obtained through a variety of data sources. The Safinamide Methanesulfonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Safinamide Methanesulfonate

Synonyms

202825-46-5, Safinamide mesilate, (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate, Pnu-151774e, Nw-1015, Safinamide (mesylate)

Cas Number

202825-46-5

Unique Ingredient Identifier (UNII)

YS90V3DTX0

Safinamide Manufacturers

A Safinamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Safinamide, including repackagers and relabelers. The FDA regulates Safinamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Safinamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Safinamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Safinamide Suppliers

A Safinamide supplier is an individual or a company that provides Safinamide active pharmaceutical ingredient (API) or Safinamide finished formulations upon request. The Safinamide suppliers may include Safinamide API manufacturers, exporters, distributors and traders.

click here to find a list of Safinamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Safinamide USDMF

A Safinamide DMF (Drug Master File) is a document detailing the whole manufacturing process of Safinamide active pharmaceutical ingredient (API) in detail. Different forms of Safinamide DMFs exist exist since differing nations have different regulations, such as Safinamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Safinamide DMF submitted to regulatory agencies in the US is known as a USDMF. Safinamide USDMF includes data on Safinamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Safinamide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Safinamide suppliers with USDMF on PharmaCompass.

Safinamide JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Safinamide Drug Master File in Japan (Safinamide JDMF) empowers Safinamide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Safinamide JDMF during the approval evaluation for pharmaceutical products. At the time of Safinamide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Safinamide suppliers with JDMF on PharmaCompass.

Safinamide KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Safinamide Drug Master File in Korea (Safinamide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Safinamide. The MFDS reviews the Safinamide KDMF as part of the drug registration process and uses the information provided in the Safinamide KDMF to evaluate the safety and efficacy of the drug.

After submitting a Safinamide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Safinamide API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Safinamide suppliers with KDMF on PharmaCompass.

Safinamide WC

A Safinamide written confirmation (Safinamide WC) is an official document issued by a regulatory agency to a Safinamide manufacturer, verifying that the manufacturing facility of a Safinamide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Safinamide APIs or Safinamide finished pharmaceutical products to another nation, regulatory agencies frequently require a Safinamide WC (written confirmation) as part of the regulatory process.

click here to find a list of Safinamide suppliers with Written Confirmation (WC) on PharmaCompass.

Safinamide NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Safinamide as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Safinamide API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Safinamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Safinamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Safinamide NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Safinamide suppliers with NDC on PharmaCompass.

Safinamide GMP

Safinamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Safinamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Safinamide GMP manufacturer or Safinamide GMP API supplier for your needs.

Safinamide CoA

A Safinamide CoA (Certificate of Analysis) is a formal document that attests to Safinamide's compliance with Safinamide specifications and serves as a tool for batch-level quality control.

Safinamide CoA mostly includes findings from lab analyses of a specific batch. For each Safinamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Safinamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Safinamide EP), Safinamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Safinamide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty